Enthera Pharmaceuticals

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Ethyreal Bio

This company develops monoclonal antibodies to treat Graves' disease and thyroid eye disease for patients with these autoimmune conditions.

DiogenX

This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.

Anthera

This biopharmaceutical company develops and commercialises medicines to treat patients suffering from inflammation, autoimmune diseases, and exocrine pancreatic insufficiency due to cystic fibrosis.

Zag Bio

This biotechnology company develops thymus-targeted bifunctional antibodies that deliver antigens to induce immune tolerance in patients with autoimmune diseases such as type 1 diabetes.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.